ERCC1 and cancer: PARP inhibitors also activated cGAS in cancer cells defective in DNA excision repair protein (ERCC1), which is involved in both nucleotide excision repair and DSB repair.105 Altogether, these studies show that PARP inhibitors activate cGAS in cancer cells and promote antitumor immunity.